Table 4.
Univariate and multivariate Cox regression analyses with mortality as the dependent variable
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Hazard ratio (95% confidence interval) | P value | Hazard ration (95% confidence interval) | P value | |
| Age | 1.051 (0.999–1.106) per year | 0.06 | ||
| Chronic obstructive lung disease | 2.99 (1.22–7.34) | 0.02 | ||
| Oral anticoagulation | 2.73 (1.17–6.39) | 0.02 | ||
| eGFR | 0.98 (0.97–0.99) per mL/min/1.73 m2 | 0.048 | ||
| Left ventricular ejection fraction | 0.95 (0.93–0.98) per % | <0.001 | 0.96 (0.94–0.99) per % | 0.01 |
| Combined pre‐capillary and post‐capillary pulmonary hypertension | 6.51 (2.81–15.08) | <0.001 | 4.58 (1.89–11.09) | 0.001 |
| Mean aortic valve gradient | 0.97 (0.94–1.00) per mmHg | 0.06 | ||
| Mitral regurgitation | 2.27 (1.41–3.67) per grade | 0.001 | ||
| FEV1 | 0.97 (0.95–0.99) per % | 0.003 | ||
| TAVR vs. SAVR | 2.70 (1.15–6.36) | 0.02 | ||
| ln BNP | 1.90 (1.33–2.71) | <0.001 | ||
BNP, B‐type natriuretic peptide; eGFR, estimated glomerular filtration rate; FEV1, forced expiratory volume within the first second; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.